Verition Fund Management
LMAT icon

Verition Fund Management’s LeMaitre Vascular LMAT Stock Holding History

Verition Fund Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,907
Closed -$1.48M – 3747
2025
Q3 		$1.48M Buy
16,907
+9,750
+136% +$871K 0.01% 2226
2025
Q2 		$594K Buy
+7,157
New +$598K ﹤0.01% 2826
2024
Q4 		– Sell
-4,472
Closed -$415K – 3384
2024
Q3 		$415K Buy
+4,472
New +$387K ﹤0.01% 2435
2024
Q2 		– Sell
-7,097
Closed -$471K – 3145
2024
Q1 		$471K Buy
7,097
+3,005
+73% +$185K ﹤0.01% 2031
2023
Q4 		$232K Sell
4,092
-2,582
-39% -$135K ﹤0.01% 1937
2023
Q3 		$364K Buy
+6,674
New +$396K ﹤0.01% 1620

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Verition Fund Management's LMAT Position: Q4 2025 in Review

Verition Fund Management sold out of LeMaitre Vascular (LMAT) in Q4 2025, closing a stake of 16,907 shares — an estimated $1.48M sold.

Verition Fund Management first reported a position in LMAT in Q3 2023 and held it in 6 quarters. The position peaked at $1.48M in Q3 2025. 297 funds tracked by Wall St. Rank hold LMAT as of Q4 2025.

  • Verition Fund Management reported no remaining LeMaitre Vascular position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 16,907 LeMaitre Vascular shares in Q4 2025, an estimated $1.48M.
  • Verition Fund Management first reported a position in LeMaitre Vascular in Q3 2023 and held it in 6 quarters.
  • Verition Fund Management's LeMaitre Vascular position peaked at $1.48M in Q3 2025.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.